Therefore, we believe that the progressive brain atrophy observed in brain MRI may be a characteristic imaging feature of ATP6AP2-related DEE; however, not unique to this disorder as other genetic-metabolic disorders could present a similar finding. Here, ATP6AP2 is linked to metabolic disease.